| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/31/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/25/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/12/2023 |
SC 13D/A
| PURA VIDA INVESTMENTS, LLC reports a 7.5% stake in Cutera, Inc. |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/15/2023 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 5% stake in iCAD Inc |
| 03/08/2023 |
4
| PURA VIDA INVESTMENTS, LLC (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Disposed of 3,890,111 shares
@ $0 |
|
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 6.8% stake in Lyra Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 3.2% stake in Pulmonx Corp |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 4.1% stake in Establishment Labs Holdings Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 6.5% stake in Nanostring Technologies, Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 7.8% stake in Cutera Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 6.6% stake in APYX MEDICAL CORPORATION |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 9% stake in ViewRay, Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 0% stake in Universe Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 10% stake in Sonendo, Inc. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 0% stake in Stryve Foods Holdings, LLC. |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 0% stake in Quotient Ltd |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 15.2% stake in Oncocyte Corp |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 0% stake in Quotient Ltd |
| 02/14/2023 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 15.2% stake in Oncocyte Corp |
| 01/25/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 5.6% stake in QUANTERIX CORP |
| 11/22/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/22/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|